Ivan Berlin1, Henian Chen, Lirio S Covey. 1. Département de Pharmacologie, Hôpital Pitié-Salpêtrière-Faculté de médicine, Université P and M. Curie, INSERM U894, Paris, France. ivan.berlin@psl.aphp.fr
Abstract
AIMS: The effect of successful and unsuccessful smoking cessation on depressive mood, anxiety- and suicide-related outcomes is unclear. The aim of this secondary analysis was to explore the relationship between abstinence status and these outcomes. DESIGN: Cohort of adult smokers attempting to stop smoking. Smoking status was assessed by a daily diary; depressed mood, anxiety and suicidal tendencies by the Hamilton Depression Rating Scale (HDRS). The association of complete and point-prevalence abstinence with the HDRS variables was assessed using multi-level linear regression models. SETTING: Randomized trial of sertraline versus placebo for smoking cessation with weekly behavioural support provided in a clinic. PARTICIPANTS: A total of 133 adult smokers with past major depression. FINDINGS:Pre-quit mood scores did not predict smoking status post-quit day. Both continuous and point-prevalence abstainers had significantly lower total HDRS, suicide and anxiety scores, adjusted for all potential confounders, during the period following quit day than did non-abstainers who experienced a significant mood deterioration. There was a significant effect of sertraline on post-quit HDRS scores but not on abstinence. CONCLUSIONS: Contrary to expectation, smoking abstinence among smokers with a history of major depression did not lead to increase in depression, anxiety or suicide ideation; however, failed quit attempts did. Persisting with a quit attempt while unable to achieve abstinence may be associated with mood deterioration.
RCT Entities:
AIMS: The effect of successful and unsuccessful smoking cessation on depressive mood, anxiety- and suicide-related outcomes is unclear. The aim of this secondary analysis was to explore the relationship between abstinence status and these outcomes. DESIGN: Cohort of adult smokers attempting to stop smoking. Smoking status was assessed by a daily diary; depressed mood, anxiety and suicidal tendencies by the Hamilton Depression Rating Scale (HDRS). The association of complete and point-prevalence abstinence with the HDRS variables was assessed using multi-level linear regression models. SETTING: Randomized trial of sertraline versus placebo for smoking cessation with weekly behavioural support provided in a clinic. PARTICIPANTS: A total of 133 adult smokers with past major depression. FINDINGS: Pre-quit mood scores did not predict smoking status post-quit day. Both continuous and point-prevalence abstainers had significantly lower total HDRS, suicide and anxiety scores, adjusted for all potential confounders, during the period following quit day than did non-abstainers who experienced a significant mood deterioration. There was a significant effect of sertraline on post-quit HDRS scores but not on abstinence. CONCLUSIONS: Contrary to expectation, smoking abstinence among smokers with a history of major depression did not lead to increase in depression, anxiety or suicide ideation; however, failed quit attempts did. Persisting with a quit attempt while unable to achieve abstinence may be associated with mood deterioration.
Authors: Daniel W Capron; Nicholas P Allan; Aaron M Norr; Michael J Zvolensky; Norman B Schmidt Journal: Addict Behav Date: 2013-12-26 Impact factor: 3.913
Authors: Jill M Williams; Michael B Steinberg; Marc L Steinberg; Kunal K Gandhi; Rajiv Ulpe; Jonathan Foulds Journal: Expert Opin Pharmacother Date: 2011-06-06 Impact factor: 3.889
Authors: Megan E Piper; Matthew Rodock; Jessica W Cook; Tanya R Schlam; Michael C Fiore; Timothy B Baker Journal: Drug Alcohol Depend Date: 2012-09-17 Impact factor: 4.492
Authors: Lirio S Covey; Mei-Chen Hu; Carla A Green; Gregory Brigham; Richard D Hurt; Lenard Adler; Theresa Winhusen Journal: Am J Drug Alcohol Abuse Date: 2011-09 Impact factor: 3.829